… Our study may provide useful information regarding dynamic changes in NAbs in patients with COVID-19 during the acute and convalescent phases and aid in the development of …
C von Rhein, T Scholz, L Henss… - Journal of virological …, 2021 - Elsevier
… COVID-19patients. The level of neutralizing antibodies vary among convalescentpatients … ), caused by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) infections, is a …
… Analysis of antibody levels and longitudinal studies of symptomatic and asymptomatic SARS-CoV-2infections in over one thousand patient samples provided insightful information …
… Recent months have seen surges of SARS-CoV-2infection across the … (c) Fold change in convalescent plasma and vaccinee sera … Data from 20 convalescentpatients or 22 vaccinated …
… patients who have recovered from COVID-19 to mitigate the development of symptoms after infection … the CCP product and convalescent donors after resolution of infection, 33 since it is …
L Zhang, Q Li, Z Liang, T Li, S Liu, Q Cui… - … microbes & infections, 2022 - Taylor & Francis
… by the existing COVID-19infection and vaccines … SARS-CoV-2 variant Omicron. The sensitivity of 28 serum samples from COVID-19convalescentpatientsinfected with SARS-CoV-2 …
Y Xing, W Ni, Q Wu, W Li, G Li, J Tong, X Song, Q Xing - medRxiv, 2020 - medrxiv.org
… While knowledge on SARS-CoV-2infection in children are still … of case reports of pediatric patients are currently available. … patients with laboratory confirmed SARS-CoV-2infection who …
A Favà, L Donadeu, N Sabé, V Pernin… - American Journal of …, 2021 - Wiley Online Library
… impairment in patients developing moderate/severe COVID-19infection, we assessed non-… occurring in patients with severe acute COVID-19infection, SARS-CoV-2 elicits robust …
ML Donato, S Park, M Baker, R Korngold, A Morawski… - JCI insight, 2021 - ncbi.nlm.nih.gov
… CCP therapy in the setting of SARS-CoV-2infection is currently an active field of investigation (11–23), but information on immune transfer, subsequent endogenous response, and …